🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the effectiveness and safety of re...
Status
Completed
Location
Local Institution - 0010
Start Date
2021-02-04
Trial ID
NCT04567615
Treatments Being Tested
The purpose of this study is to determine the safety and tolerability of ne...
Status
Active Not Recruiting
Location
Sidney Kimmel Comprehensive Cancer Center
Start Date
2021-05-28
Trial ID
NCT04658147
Treatments Being Tested
In this Phase II trial of personalized immunotherapy in R/M HNSCC, gene exp...
Status
Completed
Location
UPMC Hillman Cancer Center
Start Date
2020-05-14
Trial ID
NCT04326257
Treatments Being Tested
Background: Glioblastoma (GBM) brain tumors almost always return after tre...
Status
Completed
Location
Emory University
Start Date
2018-09-24
Trial ID
NCT03493932
Treatments Being Tested
Main Objective of this study is to examine long-term safety of nivolumab mo...
Status
Recruiting
Location
Local Institution - 0220
Start Date
2019-08-09
Trial ID
NCT03899155
Anti-PD-1 (nivolumab) or Anti-PD1/Anti LAG-3- (relaltimab) administration i...
Status
Active Not Recruiting
Location
Johns Hopkins University
Start Date
2017-07-11
Trial ID
NCT03044613
Treatments Being Tested
This phase II trial studies the effect of nivolumab in urothelial cancer th...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2021-09-21
Trial ID
NCT04953104
Treatments Being Tested
The purpose of this study is to evaluate the safety and effectiveness of tr...
Status
Completed
Location
Local Institution - 0042
Start Date
2022-05-05
Trial ID
NCT05337137
Treatments Being Tested
The purpose of this study is to demonstrate the safety and preliminary acti...
Status
Completed
Location
Local Institution - 0006
Start Date
2018-05-30
Trial ID
NCT03459222
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability, drug level...
Status
Terminated
Location
Local Institution - 0077
Start Date
2022-09-13
Trial ID
NCT05255601
Treatments Being Tested